Announcement, Biomanufacturing, Biopharmaceutical, Innovation, Manufacturing

The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has made two awards totaling $153 million to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The awards were announced today by U.S. Secretary of Commerce Gina Raimondo at the NIIMBL annual meeting in Washington, D.C.

NIIMBL...

Biopharmaceutical, Health, Innovation

NEWARK, Del. & ALEXANDRIA, Va., April 18, 2019 - The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) in partnership with the Healthcare Innovation Special Interest Group (HISIG) of the National Society of Black Engineers (NSBE) are pleased to announce the selection of seven students for the inaugural NIIMBL eXperience...

Department of Defense
Additive Manufacturing, Biopharmaceutical, Economy, Education, Health, Innovation, Manufacturing, Public Private Partnerships, STEM, Workforce

Expanding efforts focused on strengthening US-based manufacturing, the Department of Defense announced the award of a new public-private Manufacturing USA institute to Advanced Regenerative Manufacturing Institute (ARMI) today. This new institute will be the 12th Manufacturing USA institute established, with the Department of Defense now leading...

Biopharmaceutical, Design, Education, Health, Impact, Innovation, Materials, Process, Productivity, Sustainability, Workforce

Today in Newark, Delaware, Department of Commerce Secretary Penny Pritzker announced the newest institute in the Manufacturing USA network, and the first to be awarded by the National Institute of Standards and Technology (NIST) from an ”open topic” competition. The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a...